1092829-79-2 Usage
Uses
Used in Pharmaceutical Industry:
1H-Benzimidazole-5-carboxamide, 2-[(4-methoxyphenyl)amino]-1-[[2-(trifluoromethyl)phenyl]methyl]is used as a potential drug candidate for its possible biological activities. 1H-Benzimidazole-5-carboxamide, 2-[(4-methoxyphenyl)amino]-1-[[2-(trifluoromethyl)phenyl]methyl]-'s structure and functional groups may contribute to its efficacy in targeting specific molecular pathways or protein interactions, making it a valuable asset in drug development and discovery.
Used in Research and Development:
In the research field, 1H-Benzimidazole-5-carboxamide, 2-[(4-methoxyphenyl)amino]-1-[[2-(trifluoromethyl)phenyl]methyl]serves as a research tool for studying molecular pathways and protein interactions. Its unique structure allows scientists to investigate its potential effects on biological systems, which can lead to a better understanding of its properties and possible applications in medicine.
Note: The specific uses mentioned above are hypothetical and based on the general properties of benzimidazole compounds. The actual applications of 1H-Benzimidazole-5-carboxamide, 2-[(4-methoxyphenyl)amino]-1-[[2-(trifluoromethyl)phenyl]methyl]would depend on further research and development to determine its specific biological activities and potential therapeutic effects.
Check Digit Verification of cas no
The CAS Registry Mumber 1092829-79-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,2,8,2 and 9 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1092829-79:
(9*1)+(8*0)+(7*9)+(6*2)+(5*8)+(4*2)+(3*9)+(2*7)+(1*9)=182
182 % 10 = 2
So 1092829-79-2 is a valid CAS Registry Number.
1092829-79-2Relevant academic research and scientific papers
Substituted benzimidazoles: A novel chemotype for small molecule hKSP inhibitors
Lahue, Brian R.,Ma, Yao,Shipps Jr., Gerald W.,Seghezzi, Wolfgang,Herbst, Ronald
scheme or table, p. 3405 - 3409 (2010/02/28)
Substituted benzimidazoles were profiled as inhibitors of kinesin spindle protein (KSP), an increasingly important target for the development of anticancer drugs. This series demonstrated the monoastral phenotypic response and was found to be active in bo
